Post by Agilent Technologies

Scaling science is one of the biggest challenges in modern metabolomics—and one of the biggest opportunities. At the National University of Singapore, Dr. Federico Torta is advancing population-scale research by developing high-throughput workflows capable of analyzing thousands of samples while maintaining rigor and clinical relevance. Read the full story here: https://bit.ly/4ut2x7h Full video in this post: https://bit.ly/3OW5SNb From identifying biomarkers like ceramides for cardiovascular risk to coordinating the NUS–Agilent Hub, Federico Tesio Torta is helping bridge discovery science with real-world clinical impact. #Metabolomics #Lipidomics #MassSpectrometry #HighThroughput #GreatScience